Inhibition of telomerase activity by HDV ribozyme in cancers
Open Access
- 6 January 2011
- journal article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 30 (1) , 1
Abstract
Telomerase plays an important role in cell proliferation and carcinogenesis and is believed to be a good target for anti-cancer drugs. Elimination of template function of telomerase RNA may repress the telomerase activity.Keywords
This publication has 33 references indexed in Scilit:
- Catalytic Core Structure of the trans-Acting HDV Ribozyme Is Subtly Influenced by Sequence Variation Outside the CoreBiochemistry, 2006
- Cell Cycle-regulated Trafficking of Human Telomerase to TelomeresMolecular Biology of the Cell, 2006
- A Physical and Functional Constituent of Telomerase Anchor SiteJournal of Biological Chemistry, 2005
- Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cellsInternational Journal of Cancer, 2004
- Antitumor Activity of Systemically Delivered Ribozymes Targeting Murine Telomerase RNAClinical Cancer Research, 2004
- Trans-Acting Hepatitis Delta Virus Ribozyme: Catalytic Core and Global Structure Are Dependent on the 5‘ Substrate SequenceBiochemistry, 2003
- Telomerase inhibition, oligonucleotides, and clinical trialsOncogene, 2002
- Effect of Antisense Human Telomerase RNA Transfection on the Growth of Human Gastric Cancer Cell LinesBiochemical and Biophysical Research Communications, 1999
- Telomerase Activity Is Elevated in Early S Phase in Hamster CellsBiochemical and Biophysical Research Communications, 1997
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994